期刊文献+

降脂联合抗凝与单纯降脂干预对兔激素性股骨头坏死的影响对比分析 被引量:8

THE EFFECT OF LIPID LOWERING COMBINED WITH ANTI-COAGULANT ON THE TREATMENT OF CORTICOSTEROID-INDUCED OSTEONECROSIS OF FEMORAL HEAD IN RABBITS
下载PDF
导出
摘要 目的:观察降脂联合抗凝与单纯降脂干预对兔激素性股骨头坏死(ONF)的影响。方法:将52只大白兔随机分为4组:生理盐水对照组(CTR组,n=10)、激素性ONF实验组(EXP组,n=14)、阿托伐他汀联合华法林治疗组(AW组,n=14)、单纯阿托伐他汀治疗组(AT组,n=14)。利用静脉注射大肠杆菌内毒素及肌肉注射甲基强的松龙,建立兔激素性ONF动物模型。实验过程不同时点检测各组实验动物静脉血总胆固醇(TCH)、低密度脂蛋白与高密度脂蛋白比值(LDL∶HDL)及血浆凝血酶原时间(PT)变化。实验结束后处死动物,观察股骨头大体病理及骨组织形态学改变,判断ONF发生情况。结果:从实验第4周开始,与CTR组、AW组、AT组比较,EXP组TCH、LDL∶HDL显著升高(P<0.05),AW组和AT组虽高于CTR组,但组间比较差异无统计学意义(P>0.05)。从实验第2周开始,AW组PT较CTR组、EXP组及AT组明显延长(P<0.05)。AW组、AT组实验动物ONF发生率分别为31%、42%,两组间比较差异无统计学意义(P>0.05),但均显著低于EXP组67%(P<0.05)。结论:降脂与抗凝联合应用可显著降低兔激素性ONF发生,但与单纯降脂干预比较无显著差异,提示其作用可能主要从改善高脂状态中获益。 Objective: To investigate the effect of lipid lowering combined with anti-coagulant on the treat-ment of corticosteroid-induced osteonecrosis of femoral head (ONF) in rabbits. Methods: 52 rabbits wererandomized into four groups: the normal saline group (CTR group, n =10) , the experimental group (EXP group,n =14),the atorvastatin plus warfarin-treated group (AW group,n =14) and the atorvastatin-trea- ted group (AT group, n = 14). The rabbit ONF model was established by i. v. injection with endotoxin of E. coii and i. m. injection with methylprednisolone. The level of total cholesterol (TCH),the low-density lipoprotein and high-density lipoprotein ratio (LDL/HDL) and prothrombin time (PT) were measured at different time points. At the end of the experiment,the rabbits were sacrificed,and the pathologic and his- tomorphologic changes of femoral head as well as the occurrence of ONF were observed. Results: TCH lev-el and the ratio of LDL/HDL were significantly increased in the EXP group,compared ( P 〈 0. 05). The PT of the AW group was the longest among the four groups ( P 〈 0. 05). The ONF inri-dence in the EXP group was higher than those in AW and AT groups ( P 〈 0. 05). No significant differencein the incidence of ONF between AW group and AT group (31% vs. 42% , P 〉 0 . 05). Conclusion: Lipid lowering combined with anti-coagulant treatment could effectively reduce the occurrence of corticosteroid- induced ONF in rabbits, but no significant differences was found between this combination id-lowering intervention suggesting that the anti-ONF effect may rely on improving the blood lipid.
作者 彭小明 李挺松 肖增明 詹新立 Peng Xiaoming Li Tingsong Xiao Zengming Zhan Xinli.(Department of Spinal Surgery, the First Affil-iated Hospital of Guangxi Medical University,Nanning 530021,China)
出处 《广西医科大学学报》 CAS 2016年第5期766-769,共4页 Journal of Guangxi Medical University
基金 广西自然科学基金资助项目(No.2013GXNSFAA019164) 广西教育厅广西高校资助科研项目(No.201203YB044)
关键词 股骨头坏死 糖皮质激素 阿托伐他汀 华法林 osteonecrosis of femoral head cortico-steroid rabbit atorvastatin warfarin
  • 相关文献

参考文献1

二级参考文献12

  • 1Briguori C,Airoldi F,Morici N,et al. New pharmaco- logical protocols to prevent or reduce contrast media nephropathy[J]. Minerva Cardioangiol, 2005,53 ( 1 ) : 49- 58.
  • 2Toprak O. Conflicting and new risk factors for contrast induced nephropathy[J]. JUrot, 2007,178 (6) : 2 277- 2 283.
  • 3Taylor AJ, Hotehkiss D, Morse RW, et al. PREPARED:Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-tO-moder- ate renal dysfunction[J]. Chest, 1998, 114 (4): 1 570- 1 574.
  • 4MueHor C, Buerlde G, Buettner IL, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients un dergoing coronary angioplasty-J. Arch Intern Med, 2002,162(3) :329-336.
  • 5Shepherd J, Kastelein J J, Bittner V, et al. Effect of in- tensive lipid lowering with atorvastatin on renal {unc- tion in patients with coronary heart disease the Trea- ting to New Targets(TNT)study[J]. Clin J Am Soc Nephr01,2007,2(6):1 131-1 139.
  • 6Rundblack JH, Nahl D ,Yoo V. Contrast-induced ne- phropathy[J]. J Vasc Surg, 2011,54(2) : 575-579.
  • 7Patti G,Nusca A,CheHo M,et al. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergo-ing pereutaneous coronary intervention[J].AmJ Cardi- ol,2008,101(3):279-285.
  • 8Dulak J, Loboda A,Jazwa A. Atorvastatin affects sev- eral angiogenic mediators in human endothelial ceils [J]. Endothelium,2005 ,12 ( 5-6 ) :233,241.
  • 9Loboda A,Jazwa A,Jozkowiez A. Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heine oxygen- ase-1 in human microvascular endothelial cells[J]. Ath- erosclerosis, 2006,187 ( 1 ) :26-30.
  • 10Sabbatini M, Pisani A, UceeHo F, et al. Atorvastatin improves the course of ischemic acute renal failure in aging rats[J]. J Am Soc Nephr,2004,15(4):901-909.

同被引文献114

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部